Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Accumulated Expenses: 2021-2025

Historic Accumulated Expenses for Roivant Sciences (ROIV) over the last 5 years, with Mar 2025 value amounting to $114.3 million.

  • Roivant Sciences' Accumulated Expenses fell 2.83% to $108.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $108.3 million, marking a year-over-year decrease of 2.83%. This contributed to the annual value of $114.3 million for FY2025, which is 4.29% down from last year.
  • Latest data reveals that Roivant Sciences reported Accumulated Expenses of $114.3 million as of FY2025, which was up 9.56% from $104.3 million recorded in FY2024.
  • Roivant Sciences' 5-year Accumulated Expenses high stood at $167.1 million for FY2023, and its period low was $76.9 million during FY2021.
  • In the last 3 years, Roivant Sciences' Accumulated Expenses had a median value of $119.4 million in 2024 and averaged $125.5 million.
  • Its Accumulated Expenses has fluctuated over the past 5 years, first skyrocketed by 65.76% in 2022, then declined by 28.55% in 2024.
  • Yearly analysis of 5 years shows Roivant Sciences' Accumulated Expenses stood at $76.9 million in 2021, then reached $112.7 million in 2021, then skyrocketed by 65.76% to $127.5 million in 2022, then increased by 17.47% to $132.4 million in 2022, then soared by 31.05% to $167.1 million in 2023, then declined by 7.71% to $122.1 million in 2023, then fell by 28.55% to $119.4 million in 2024, then declined by 14.59% to $104.3 million in 2024, then dropped by 4.29% to $114.3 million in 2025.